Why Angiodynamics Stock Sank Today
A fairly uninspiring set of quarterly results pushed (NASDAQ: ANGO) stock down in value on Wednesday. The medical device and technology company saw its share price dip by almost 3% on the day, contrasting with the 0.8% gain of the S 500 index.
For its first quarter of fiscal 2024, AngioDynamics booked net sales of $78.7 million. The two revenue streams that make up that figure, medical technology and medical devices, both saw increases. Technology posted the largest leap, with its take rising by over 13% year over year to $25.9 million. Devices advanced by slightly more than 2% to $52.8 million.
As for profitability, AngioDynamics posted a non-GAAP (adjusted) net loss of $4.8 million ($0.12 per share), nearly double the $2.5 million deficit in the same quarter of fiscal 2023.
Source Fool.com
Angiodynamics Inc. Aktie
Die Angiodynamics Inc. Aktie hat zu wenige Einschätzungen, um eine Tendenz festzustellen.
Ein positives Kurspotenzial für Angiodynamics Inc. ist gegeben, mit einem Kursziel von 13 € über dem aktuellen Kurs von 12.7 €.
